MIM
INSM icon

Macroview Investment Management’s Insmed INSM Stock Holding History

Macroview Investment Management’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-174
Closed -$4K – 327
2019
Q4 		$4K Buy
+174
New +$3.54K 0.01% 192
2019
Q3 		– Sell
-153
Closed -$4K – 309
2019
Q2 		$4K Buy
+153
New +$4.26K 0.01% 195

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Macroview Investment Management's INSM Position: Q1 2020 in Review

Macroview Investment Management sold out of Insmed (INSM) in Q1 2020, closing a stake of 174 shares — an estimated $4K sold.

Macroview Investment Management first reported a position in INSM in Q2 2019 and held it in 2 quarters. The position peaked at $4K in Q4 2019. 165 funds tracked by Wall St. Rank hold INSM as of Q1 2020.

  • Macroview Investment Management reported no remaining Insmed position as of Q1 2020 after selling out during the quarter.
  • Macroview Investment Management sold 174 Insmed shares in Q1 2020, an estimated $4K.
  • Macroview Investment Management first reported a position in Insmed in Q2 2019 and held it in 2 quarters.
  • Macroview Investment Management's Insmed position peaked at $4K in Q4 2019.
  • 165 funds tracked by Wall St. Rank held Insmed as of Q1 2020.

Based on Macroview Investment Management's 13F filing for Q1 2020, filed 6 May 2020.